← Back to Search

Interpersonal Therapy for Depression

N/A

Waitlist Available

Research Sponsored by University of Illinois at Urbana-Champaign

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months post pregnancy

Awards & highlights

Study Summary

This trial will study whether interpersonal therapy is more effective than usual treatment in pregnant women with depression.

Eligible Conditions

Depression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months post pregnancy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months post pregnancy

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post pregnancy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Presence of a Major Depressive Episode on SCID interview

Symptom Checklist 20 (SCL20)

Secondary outcome measures

Edinburgh Postnatal Depression Scale (EPDS)

Work and Social Adjustment Scale (WSAS)

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Behavioral: Interpersonal TherapyExperimental Treatment1 Intervention

Individual psychotherapy that includes an initial engagement session and a total of 8 sessions. IPT focuses on psychoeducation and interpersonal skill building to decrease interpersonal conflict and increase interpersonal support and competence.

Group II: Enhanced Usual CarePlacebo Group1 Intervention

Maternity support services (MSS) is the usual standard of care for pregnant women. A multi-disciplinary team of obstetric care providers routinely screen women for possible depression diagnosis. If a woman screens positive, she is seen by a behavioral health specialist (BHS) for further assessment and to initiate treatment, if necessary. The goals of MSS include offering services to promote healthy pregnancies and positive birth and parenting outcomes, including integrating mental health and prenatal care. Women with elevated depressive symptoms are seen by BHS throughout the pregnancy and postpartum period and then bridged to mental health treatment. BHS provides eclectic-based care but does not provide IPT.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Interpersonal Therapy

2002

Completed Phase 4

~900

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of DenverOTHER

23 Previous Clinical Trials

10,001 Total Patients Enrolled

6 Trials studying Depression

3,865 Patients Enrolled for Depression

National Institute of Mental Health (NIMH)NIH

2,782 Previous Clinical Trials

2,688,867 Total Patients Enrolled

665 Trials studying Depression

251,194 Patients Enrolled for Depression

University of Illinois at Urbana-ChampaignLead Sponsor

188 Previous Clinical Trials

37,095 Total Patients Enrolled

4 Trials studying Depression

664 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects will be included in this experiment?

"Affirmative. Information posted on clinicaltrials.gov confirms that this medical study, initially launched in September 2017, is presently enrolling subjects. Approximately 240 individuals are necessary to be enrolled from 2 distinct sites."

Answered by AI

Is this medical research currently recruiting participants?

"The trial is actively seeking participants, as indicated by its last update on clinicaltrials.gov dated February 10th 2021. It was initially published four years prior, in September 2017."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms

2017. "Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03011801.